Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals

This publication has 49 references indexed in Scilit:

• New Characteristics of Anti-Factor VIII Inhibitor Antibody Epitopes and Unusual Immune Responses to Factor VIII
  Seminars in Thrombosis and Hemostasis, 2002
• Immunology of Factor VIII Inhibitors
  Seminars in Thrombosis and Hemostasis, 2002
• Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
  New England Journal of Medicine, 2002
• Neutralizing antibodies to granulocyte–macrophage colony‐stimulating factor, interleukin‐1α and interferon‐α but not other cytokines in human immunoglobulin preparations
  Immunology, 2000
• Detection and Characterization of Antibodies to PEG-IFN-alpha2b Using Surface Plasmon Resonance
  Journal of Interferon & Cytokine Research, 1999
• The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2
  European Journal Of Cancer, 1994
• Roferon (rIFN-α_2a) Is More Immunogenic Than Intron A (rIFN-α_2b) in Patients with Chronic Myelogenous Leukemia
  Journal of Interferon Research, 1994
• ANTIGENICITY AND EFFICACY OF AUTHENTIC SEQUENCE RECOMBINANT HUMAN GROWTH HORMONE (SOMATROPIN): FIRST‐YEAR EXPERIENCE IN THE UNITED KINGDOM
  Clinical Endocrinology, 1989
• Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies
  New England Journal of Medicine, 1988
• CLINICAL STUDIES WITH RECOMBINANT-DNA-DERIVED METHIONYL HUMAN GROWTH HORMONE IN GROWTH HORMONE DEFICIENT CHILDREN
  The Lancet, 1986